A novel cell-based assay for the high-throughput screening of epithelial-mesenchymal transition inhibitors: Identification of approved and investigational drugs that inhibit epithelial-mesenchymal transition.
Lung Cancer. 2023 Jan;175:36-46. doi: 10.1016/j.lungcan.2022.11.015. Epub 2022 Nov 23.
Lung Cancer. 2023.
PMID: 36450215